169 related articles for article (PubMed ID: 29171346)
1. Computational and in vitro insights on snake venom phospholipase A
Muthusamy K; Chinnasamy S; Nagarajan S; Sivaraman T
J Biomol Struct Dyn; 2018 Dec; 36(16):4197-4208. PubMed ID: 29171346
[TBL] [Abstract][Full Text] [Related]
2. Isolation and characterization of bioactive compounds of Clematis gouriana Roxb. ex DC against snake venom phospholipase A
Muthusamy K; Chinnasamy S; Nagarajan S; Sivaraman T; Chinnasamy S
J Biomol Struct Dyn; 2017 Jul; 35(9):1936-1949. PubMed ID: 27355444
[TBL] [Abstract][Full Text] [Related]
3. High-affinity selective inhibitor against phospholipase A2 (PLA2): a computational study.
Chinnasamy S; Chinnasamy S; Muthusamy K
J Recept Signal Transduct Res; 2016; 36(2):111-8. PubMed ID: 26422703
[TBL] [Abstract][Full Text] [Related]
4. Combining in silico and in vitro approaches to identification of potent inhibitor against phospholipase A2 (PLA2).
Chinnasamy S; Selvaraj G; Selvaraj C; Kaushik AC; Kaliamurthi S; Khan A; Singh SK; Wei DQ
Int J Biol Macromol; 2020 Feb; 144():53-66. PubMed ID: 31838071
[TBL] [Abstract][Full Text] [Related]
5. Molecular docking and dynamic studies of crepiside E beta glucopyranoside as an inhibitor of snake venom PLA2.
Kumar MS; R A; Bhaskaran S; D DR; Nair AS; R SP
J Mol Model; 2019 Mar; 25(4):88. PubMed ID: 30847632
[TBL] [Abstract][Full Text] [Related]
6. Virtual analysis of structurally diverse synthetic analogs as inhibitors of snake venom secretory phospholipase A2.
Sivaramakrishnan V; Ilamathi M; Ghosh KS; Sathish S; Gowda TV; Vishwanath BS; Rangappa KS; Dhananjaya BL
J Mol Recognit; 2016 Jan; 29(1):22-32. PubMed ID: 26218369
[TBL] [Abstract][Full Text] [Related]
7. Molecular modeling and snake venom phospholipase A2 inhibition by phenolic compounds: Structure-activity relationship.
Alam MI; Alam MA; Alam O; Nargotra A; Taneja SC; Koul S
Eur J Med Chem; 2016 May; 114():209-19. PubMed ID: 26986086
[TBL] [Abstract][Full Text] [Related]
8. Metabolites from the citrus extracts inhibit the activity of selected proteins in Indian Cobra (Naja naja) venom.
R S; Gurunathan J
J Ethnopharmacol; 2020 Apr; 252():112575. PubMed ID: 31953201
[TBL] [Abstract][Full Text] [Related]
9. Gallic acid anti-myotoxic activity and mechanism of action, a snake venom phospholipase A
Costa TR; Francisco AF; Cardoso FF; Moreira-Dill LS; Fernandes CAH; Gomes AAS; Guimarães CLS; Marcussi S; Pereira PS; Oliveira HC; Fontes MRM; Silva SL; Zuliani JP; Soares AM
Int J Biol Macromol; 2021 Aug; 185():494-512. PubMed ID: 34197854
[TBL] [Abstract][Full Text] [Related]
10. The biflavonoid morelloflavone inhibits the enzymatic and biological activities of a snake venom phospholipase A2.
Pereañez JA; Patiño AC; Núñez V; Osorio E
Chem Biol Interact; 2014 Sep; 220():94-101. PubMed ID: 24995575
[TBL] [Abstract][Full Text] [Related]
11. Quercetin-3-O-rhamnoside from Euphorbia hirta protects against snake Venom induced toxicity.
Gopi K; Anbarasu K; Renu K; Jayanthi S; Vishwanath BS; Jayaraman G
Biochim Biophys Acta; 2016 Jul; 1860(7):1528-40. PubMed ID: 27033089
[TBL] [Abstract][Full Text] [Related]
12. Sulfur Compounds as Inhibitors of Enzymatic Activity of a Snake Venom Phospholipase A
Henao Castañeda I; Pereañez JA; Preciado LM; Jios J
Molecules; 2020 Mar; 25(6):. PubMed ID: 32197309
[TBL] [Abstract][Full Text] [Related]
13. In Silico and In Vitro Study of the Bromelain-Phytochemical Complex Inhibition of Phospholipase A2 (Pla2).
Mohamed Tap F; Abd Majid FA; Ismail HF; Wong TS; Shameli K; Miyake M; Ahmad Khairudin NB
Molecules; 2018 Jan; 23(1):. PubMed ID: 29351216
[TBL] [Abstract][Full Text] [Related]
14. Temperature effect in the inhibition of PLA
Diniz EADS; da Silva DP; Ferreira SS; Fernandes-Pedrosa MF; Vieira DS
J Biomol Struct Dyn; 2024 Jul; 42(10):5238-5252. PubMed ID: 37378497
[TBL] [Abstract][Full Text] [Related]
15. In silico and in vitro neutralization of PLA
Devi A; Namsa ND; Doley R
Int J Biol Macromol; 2020 Dec; 165(Pt A):1066-1078. PubMed ID: 33035526
[TBL] [Abstract][Full Text] [Related]
16. Deciphering the interactions of scopoletin and scopolin from Catunaregam nilotica roots against Naja nigricollis phospholipase A
Salihu M; Hassan LG; Faruq UZ; Yusuf AJ
Toxicon; 2024 May; 243():107732. PubMed ID: 38642905
[TBL] [Abstract][Full Text] [Related]
17. Identification of novel inhibitors of Daboia russelli phospholipase A2 using the combined pharmacophore modeling approach.
Ramakrishnan C; Joshi V; Joseph JM; Vishwanath BS; Velmurugan D
Chem Biol Drug Des; 2014 Oct; 84(4):379-92. PubMed ID: 24703201
[TBL] [Abstract][Full Text] [Related]
18. Structure-based grafting, mutation, and optimization of peptide inhibitors to fit in the active pocket of human secreted phospholipase A2: find new use of old Peptide agents with anti-inflammatory activity.
Zhan C; Li S; Zhong Q; Zhou D
Chem Biol Drug Des; 2015 Apr; 85(4):418-26. PubMed ID: 25187416
[TBL] [Abstract][Full Text] [Related]
19. Molecular dynamics simulations reveal structural insights into inhibitor binding modes and functionality in human Group IIA phospholipase A
Kim RR; Malde AK; Nematollahi A; Scott KF; Church WB
Proteins; 2017 May; 85(5):827-842. PubMed ID: 28056488
[TBL] [Abstract][Full Text] [Related]
20. Identification of potent inhibitors against snake venom metalloproteinase (SVMP) using molecular docking and molecular dynamics studies.
Chinnasamy S; Chinnasamy S; Nagamani S; Muthusamy K
J Biomol Struct Dyn; 2015; 33(7):1516-27. PubMed ID: 25192471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
